



| 카탈로그 번호 | JN969016 |
|---|---|
| 설명 |
Berlimatoxumab (JN969016) is a research-grade recombinant antibody targeting lukG. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 종 반응성 | Staphylococcus aureus |
| 응용 분야 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 숙주 종 | Human |
| 클론성 | Monoclonal |
| 이소타입 | IgG1-kappa |
| 발현 시스템 | Mammalian cells |
| 타겟 | lukG |
| 내독소 수준 | < 10 EU/mg |
| 순도 | >95% purity as determined by SDS-PAGE. |
| 정제 | Protein A/G purified from cell culture supernatant. |
| 등록번호 | A0A6B5MC52 |
| 형태 | Liquid |
| 저장 완충액 | 0.01M PBS pH 7.4 데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요. |
| 안정성 및 저장 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 대체 이름 | ASN-100(combinationofatidortoxumabandberlimatoxumab), ASN-2, 1939109-24-6 |
| 배경 | Berlimatoxumab (ASN-2) is an antibody. Berlimatoxumab can be used for experiment research. • Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins., PMID:24586678 • Molecular mechanism of leukocidin GH-integrin CD11b/CD18 recognition and species specificity., PMID:31852826 • Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies., PMID:27467113 • Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH., PMID:25371205 • Adaptive laboratory evolution and independent component analysis disentangle complex vancomycin adaptation trajectories., PMID:35858453 • Human antibody responses against non-covalently cell wall-bound Staphylococcus aureus proteins., PMID:29459694 • Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics., PMID:20661294 • Serum neutralizing antibody after rabies postexposure prophylaxis., PMID:945973 • Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening., PMID:29176494 • Vitamin E regulates mitochondrial hydrogen peroxide generation., PMID:10490278 |
| 참고사항 | For research use only. Not suitable for clinical or therapeutic use. |

SEC-HPLC detection for Research Grade Berlimatoxumab.

SDS-PAGE for Research Grade Berlimatoxumab.




+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206

中文
English
한국어
日本語
Español
Français
Русский